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Pulmonary surfactant and cardiopulmonary bypass
in infants 
To the Editor:
We read with interest the recent article by Paul and col-
leagues1 describing changes in pulmonary surfactant after
cardiopulmonary bypass (CPB) in a group of infants having
surgery for congenital heart disease.
In this article the authors report concentrations of phos-
pholipid and, indirectly, protein in returned fluid from tra-
cheal lavage. There is no apparent attempt to correct concen-
trations for variable recovery of epithelial lining fluid in these
specimens. To define the concentration of surfactant compo-
nents in sampled secretions, a marker of dilution should be
used, allowing the result to be expressed as concentration in
epithelial lining fluid.2 Results expressed as concentrations in
raw lavage fluid are impossible to interpret meaningfully.
Paul and colleagues do report the phospholipid/protein
ratio of tracheal lavage specimens. This ratio does nothing to
clarify the data and certainly cannot be interpreted as an
attempt to correct for dilution, given their later statement that
alveolar protein concentration is known to be increased after
CPB. A useful marker of dilution of epithelial lining fluid
must not be present in increased concentration in the dam-
aged lung. For this reason protein (along with albumin and
sphingomyelin) is not suitable in this population.3
Paul and colleagues report a significant fall in total phos-
pholipid concentration immediately after CPB. In their dis-
cussion they state: “Our data support the findings of
McGowan and colleagues, who demonstrated an alteration in
surfactant composition in older infants and children after
CPB.” In fact, these findings are at odds with those of
McGowan and colleagues,4 who found no difference in total
phosphatidylcholine recovered by bronchoalveolar lavage
before and after CPB. In the other published study looking at
phospholipid after CPB in children, LeVine and colleagues5
showed no difference in phosphatidylcholine levels between
a group of children who had undergone CPB and a control
group. Both of these studies involved greater numbers of
patients having CPB than in that of Paul and colleagues, and
both are also subject to the same criticism of not appropriately
correcting results for dilution.
There may well be significant abnormalities of pulmonary
surfactant that contribute to postoperative lung dysfunction in
this patient population. McGowan and colleagues4 did find a
change in the proportion of phospholipid in pulmonary sur-
factant subtypes after CPB (a measurement not influenced by
dilution of specimens), which would have important func-
tional implications. This subject warrants further investiga-
tion, but care must be taken to express findings in a way that
will add to our understanding of the consequences of CPB on
the composition and function of pulmonary surfactant.
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Reply to the Editor:
We thank Millar and colleagues for their interest in our arti-
cle, “The Role of Cardiopulmonary Bypass and Surfactant in
Pulmonary Decompensation after Surgery for Congenital
Heart Disease.”1 We concur that our data have certain limita-
tions and must be interpreted with a degree of caution.
Although we did not account for the variable recovery of
epithelial lining fluid by using a marker of dilution, we made
every effort to standardize the timing and technique of the
lavage fluid with each procedure. Although a measurement of
dilution may have been helpful, even this method has poten-
tial limitations2 and, as mentioned in the letter, our method is
similar to that used in other studies in children undergoing
bypass for congenital heart disease.3,4 Millar and colleagues
also pointed out the potential limitations to using total protein
as the denominator. However, as stated in our conclusions, we
